Assessment of Treatment Outcome in Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors: Insight From a Resource Limited Setting

Assessment of Treatment Outcome in Chronic Myelogenous Leukemia Patients on Tyrosine Kinase Inhibitors: Insight From a Resource Limited Setting

ABSTRACT Background Chronic myeloid leukemia (CML) is a hematologic malignancy characterized by the translocation t(9;22)(q34;q11.2), which results in a constitutively active tyrosine kinase. The introduction of tyrosine kinase inhibitors (TKIs) has significantly altered the disease course for patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Wude Yewondwosen Awlachew, Abel Tenaw Tasamma, Firehiwot Abebe Mengistie, Zekarias Tadele Alemineh, Samuel Tesfaye Tefera
Format: Article
Language:English
Published: Wiley 2025-02-01
Series:Cancer Medicine
Subjects:
chronic myelogenous leukemia
TASH
treatment pattern
Online Access:https://doi.org/10.1002/cam4.70635
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items